MYH9 inhibits the activity of the bidirectional promoter shared by Forkhead Box E1 (FOXE1) and the lncRNA gene papillary thyroid carcinoma susceptibility candidate 2 (PTCSC2) [235]. The gene discussed is FOXE1; the disease is differentiated thyroid carcinoma.